Compounding pharmacies in Utah with FDA records
Which compounding pharmacies in Utah have FDA records?
GLP-1 Ledger lists 2 compounding pharmacies and outsourcing facilities in Utah named in FDA records: 0 on FDA’s registered outsourcing facility list (updated Nov 6, 2026) and 2 with an entry on FDA’s compounding inspections and actions page (current as of Oct 22, 2026), 0 of them with at least one FDA warning letter listed there. State board of pharmacy records for Utah are not checked: the Division of Professional Licensing’s website refused automated requests, and this index does not work around blocks.
The list covers pharmacies FDA names on its 503B list or its compounding inspections and actions page, for all drugs, not only GLP-1s. The Utah board of pharmacy licenses pharmacies and keeps its own records, which this index has not checked.
| Intermountain Medical Center | Murray | 503A | No matching record found | Not checked | 0 | 0 | Oct 25, 2019 |
| Red Rock Pharmacy (CD Pharmacy LLC) | Springville | 503A | No matching record found | Not checked | 1 | 0 | Jul 31, 2026 |
FDA 503B list column: “Record found” means FDA’s registered outsourcing facility list names the pharmacy at this location; “No matching record found” means no row matched by name and location when this index last checked. Form 483, warning letter and latest action columns count what FDA’s compounding inspections and actions page lists; a 503B list row’s own inspection columns are on its facility page. State license column: “License found” means the state board file lists a license with the same name and city; “No exact match” means it does not, which is not a finding that the pharmacy is unlicensed; “Not checked” means this index does not read that board’s license records.
Other states
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
Records last pulled Nov 15, 2026. Every entry links to the original public record.